S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.94%) $83.06
Gas
(-1.16%) $1.619
Gold
(-0.27%) $2 340.80
Silver
(-0.33%) $27.45
Platinum
(0.63%) $927.90
USD/EUR
(-0.14%) $0.933
USD/NOK
(-0.14%) $11.01
USD/GBP
(-0.21%) $0.799
USD/RUB
(0.00%) $92.17

リアルタイムの更新: Elekta AB (publ) [EKTAY]

取引所: OTC セクター: Healthcare 産業: Medical Instruments & Supplies
最終更新日時27 4月 2024 @ 04:37

2.31% $ 6.86

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 04:37):

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology...

Stats
本日の出来高 32 188.00
平均出来高 9 071.00
時価総額 2.52B
EPS $0 ( 2024-03-01 )
次の収益日 ( $0 ) 2024-05-23
Last Dividend $0.117 ( 2023-08-25 )
Next Dividend $0 ( N/A )
P/E 19.59
ATR14 $0.0210 (0.31%)

Elekta AB (publ) 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Elekta AB (publ) 財務諸表

Annual 2023
収益: $16.87B
総利益: $6.35B (37.64 %)
EPS: $2.47
FY 2023
収益: $16.87B
総利益: $6.35B (37.64 %)
EPS: $2.47
FY 2022
収益: $14.55B
総利益: $5.44B (37.37 %)
EPS: $3.02
FY 2021
収益: $13.76B
総利益: $5.61B (40.76 %)
EPS: $3.28

Financial Reports:

No articles found.

Elekta AB (publ) Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.118
(N/A)
$0
(N/A)
$0.118
(N/A)
$0
(N/A)
$0.117
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Elekta AB (publ) Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.91 - Stable (1.85%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.305 2013-09-04
Last Dividend $0.117 2023-08-25
Next Dividend $0 N/A
Payout Date 2023-09-15
Next Payout Date N/A
# dividends 18 --
Total Paid Out $1.985 --
Avg. Dividend % Per Year 0.00% --
Score 3.83 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.91
Div. Directional Score 8.83 --
Next Divdend (Est)
(2024-10-03)
$0.123 Estimate 7.07 %
Dividend Stability
0.28 Very Poor
Dividend Score
3.83
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SAFRY Ex Dividend Junior 2023-05-30 Annually 0 0.00%
FMBL Ex Dividend Junior 2023-09-14 Quarterly 0 0.00%
WRTBY Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%
MCHB Ex Dividend Knight 2023-08-09 Annually 0 0.00%
CNAF Ex Dividend Knight 2023-08-24 Quarterly 0 0.00%
SONVY Ex Dividend Knight 2023-06-14 Annually 0 0.00%
HEGIY Ex Dividend Knight 2023-09-15 Semi-Annually 0 0.00%
ANIOY Ex Dividend Knight 2023-07-13 Annually 0 0.00%
NODB Ex Dividend Junior 2023-10-17 Quarterly 0 0.00%
CUYTY Ex Dividend Junior 2023-09-29 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07861.5008.4310.00[0 - 0.5]
returnOnAssetsTTM0.04661.2008.4510.00[0 - 0.3]
returnOnEquityTTM0.1411.5009.5410.00[0.1 - 1]
payoutRatioTTM0.640-1.0003.60-3.60[0 - 1]
currentRatioTTM1.0950.8009.537.62[1 - 3]
quickRatioTTM0.8220.8009.877.90[0.8 - 2.5]
cashRatioTTM0.1811.500-0.104-0.156[0.2 - 2]
debtRatioTTM0.198-1.5006.70-10.00[0 - 0.6]
interestCoverageTTM6.241.0008.808.80[3 - 30]
operatingCashFlowPerShareTTM8.212.007.2610.00[0 - 30]
freeCashFlowPerShareTTM3.982.008.0110.00[0 - 20]
debtEquityRatioTTM0.593-1.5007.63-10.00[0 - 2.5]
grossProfitMarginTTM0.3771.0007.047.04[0.2 - 0.8]
operatingProfitMarginTTM0.1291.0009.419.41[0.1 - 0.6]
cashFlowToDebtRatioTTM0.5161.0008.258.25[0.2 - 2]
assetTurnoverTTM0.5930.8009.387.50[0.5 - 2]
Total Score12.75

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM20.001.0008.080[1 - 100]
returnOnEquityTTM0.1412.509.7010.00[0.1 - 1.5]
freeCashFlowPerShareTTM3.982.008.6710.00[0 - 30]
dividendYielPercentageTTM0.3091.5002.270[0 - 0.4]
operatingCashFlowPerShareTTM8.212.007.2610.00[0 - 30]
payoutRatioTTM0.6401.5003.60-3.60[0 - 1]
pegRatioTTM-0.1001.500-4.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1721.0008.200[0.1 - 0.5]
Total Score4.91

Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。